King-Devick technologies, inc. offers a broad set of evidence-based tools utilizing integrated technology to accurately and objectively assess eye movement (oculomotor) disorders such as saccadic dysfunction associated with changes in neurological function.

King-Devick products have been scientifically validated in more than 140 recent peer-reviewed articles published in elite medical journals related to concussion management, reading solutions, migraines, Alzheimer’s disease, hypoxia, multiple sclerosis, Parkinson’s disease, extreme sleep deprivation and ALS.

Key Relationships

King-Devick Test in association
with Mayo Clinic

In an effort to increase concussion screening awareness, in 2015, Mayo Clinic and King-Devick technologies, inc. announced that they had executed a licensing agreement to co-brand the King-Devick sideline test to King-Devick Test in association with Mayo Clinic. Read the complete press release here.


King-Devick Reading
Acceleration Program

In 2017, global learning company Houghton Mifflin Harcourt partnered with King-Devick technologies, inc. to bring the King-Devick Reading Acceleration Program, a new proven-effective approach to strengthening literacy skills by teaching the physical act of reading, to students in elementary classrooms. Read the complete press release here.

Share This Page